Cargando…
LGG-32. Integrated biologic, radiologic and clinical analysis of pediatric low-grade gliomas during and after targeted therapy treatment
BACKGROUND: Pediatric low grade gliomas (pLGGs) are the most common central nervous system tumor in children, characterized by driver alterations in the RAS and MAPK pathways. Genomic advances have facilitated use of molecular targeted therapies, however their long-term impact on tumor behavior rema...
Autores principales: | Tsai, Jessica W, Choi, Jungwhan John, Ouaalam, Hakim, Murrillo, Efrain Aguilar, Yeo, Kee Kiat, Vogelzang, Jayne, Sousa, Cecilia, Woods, Jared K, Ligon, Keith L, Warfield, Simon K, Bandopadhayay, Pratiti, Cooney, Tabitha M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165407/ http://dx.doi.org/10.1093/neuonc/noac079.344 |
Ejemplares similares
-
LGG-03. LONG-TERM FOLLOW UP OF TARGETED THERAPY IN PEDIATRIC LOW-GRADE GLIOMAS: THE DANA-FARBER/BOSTON CHILDREN’S EXPERIENCE
por: Tsai, Jessica, et al.
Publicado: (2021) -
LGG-48. The influence of different FGFR1 alterations on pediatric low-grade glioma tumor biology and targeted therapy response
por: Morin, Eric, et al.
Publicado: (2022) -
LGG-59. Identifying hidden drivers of low-grade glioma tumor growth
por: Misek, Sean, et al.
Publicado: (2022) -
LGG-45. Genetic dependencies inMYB/MYBL1-driven pediatric low-grade glioma models
por: Condurat, Alexandra-Larisa, et al.
Publicado: (2022) -
LGG-58. Understanding the transcriptional heterogeneity of pediatric low-grade gliomas and its implication for tumor pathophysiology
por: Boisvert, Michelle, et al.
Publicado: (2022)